VERTEX PHARMS INC
Trikafta
Resolved
102days ago
Approval decision · Mar 27, 2026
What's at stake
A final FDA approval decision on Trikafta for its lead indication is expected Mar 27, 2026.
Primary source
· openFDA
verified 18h ago
“FDA approved Trikafta (NDA212273) — sponsor VERTEX PHARMS INC; efficacy supplement (Efficacy); FDA action date 2026-03-27.”